ENG and neuroblastoma: Therefore, even though the induction of ADCC in vivo with anti-GD2 and anti-CD105 mAbs offers a promising immunotherapeutic tool (since both markers are expressed by NB stromal and cancer cells) [36,37,38,61], this approach may be ineffective in the case of resistant NB-MSC-like cells [50].